What does CUSIP 457637502 represent in this 13F holders report?

CUSIP 457637502 is the security identifier for INM - InMed Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held INM - InMed Pharmaceuticals Inc. - Common Stock in Q1 2021?

12 institutional investors reported INM - InMed Pharmaceuticals Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

InMed Pharmaceuticals Inc. - Common Stock (INM)

CUSIP: 457637502

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / Common Stock
Total 13F shares: 457,636
Total 13F value: $1,509,962
Share change: +423,563
SEC-reported price per share: $3.30
Number of holders: 12
Value change: +$1,397,969
Number of buys: 7
Shares outstanding: 737,449

Security key

457637502

Report period

Q1 2021

Institutions

Top holders

INM full security history Ownership snapshot Full 13F holder table InMed Pharmaceuticals Inc. SEC filings InMed Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BANK OF AMERICA CORP /DE/

Disclosed value leader

BANK OF AMERICA CORP /DE/

Comparable rows

11/11

Latest evidence

31 Dec 2020

13F Lead comparable stake: 1.7% Showing 1-6 of 11 holder rows.

Quick read

BANK OF AMERICA CORP /DE/ leads the comparable SEC ownership view at 1.7%.

11 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BANK OF AMERICA CORP /DE/'s linked filing trail.

Comparable ownership Top 5

BANK OF AMERICA CORP /DE/ 1.7%

Creative Planning 1.5%

MORGAN STANLEY 0.97%

JPMORGAN CHASE & CO 0.86%

PNC FINANCIAL SERVICES GROUP, INC. 0.25%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 11 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BANK OF AMERICA CORP /DE/	13F Company 13F	1.7%	$42,000 12,720 shares	—	31 Dec 2020
Creative Planning	13F Company 13F	1.5%	$36,000 10,990 shares	—	31 Dec 2020
MORGAN STANLEY	13F Company 13F	0.97%	$23,000 7,122 shares	—	31 Dec 2020
JPMORGAN CHASE & CO	13F Company 13F	0.86%	$21,000 6,372 shares	—	31 Dec 2020
PNC FINANCIAL SERVICES GROUP, INC.	13F Company 13F	0.25%	$6,000 1,820 shares	—	31 Dec 2020
OSAIC HOLDINGS, INC.	13F Company 13F	0.12%	$4,000 921 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

457,636

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %